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Abstract
Background Postoperative infection associated with
implants remains a serious complication in orthopedic
surgery. Several biomaterial surface treatments have been
proposed as a means of reducing the incidence of implant-
associated infections. In this study, a clinical trial was
performed using an iodine-supported titanium that sup-
presses the microbial activities.
Methods A total of 222 patients with postoperative
infection or compromised status were treated using iodine-
supported titanium implants. The mean age of the patients
was 49.4 years (range 5–85 years). One hundred twenty-
seven patients were male and 95 were female. In 158
patients, iodine-supported implants were used to prevent
infection, such as compromised hosts and conditions, and
in 64 patients to treat active infection. White blood cell
(WBCs) and C-reactive protein (CRP) levels were mea-
sured pre- and postoperatively in all patients. To confirm
whether iodine from the implant affected physiological
functions, thyroid hormone levels in the blood were
examined. Both examinations were conducted sequentially
for a year. Radiological evaluations were performed reg-
ularly after the operation. The chronological changes of the
iodine amount were evaluated using half pins removed
after completion of external fixation.
Results The mean follow-up period was 18.4 months
(range 3–44 months). Acute infection developed in three
tumor cases among the 158 patients on preventive therapy.
All three recovered without removal of the implants.
Infection was cured in all 64 patients with infection.
Median WBC levels were in the normal range, and median
CRP levels returned to \0.5 within 4 weeks after surgery.
Abnormalities of thyroid gland function were not detected.
None of the patients experienced loosening of the implants.
There were two patients with mechanical implant failure,
which was treated by re-implantation. Excellent bone
ingrowth and ongrowth were found around all hip and
tumor prostheses. One year later, the amount of iodine on
external fixation pins remained about 20–30 %.
Conclusions Iodine-supported titanium implants can be
very effective for preventing and treating infections after
orthopedic surgery. Cytotoxicity and adverse effects were
not detected.
Introduction
Surgical site infection associated with implants remains a
serious and common complication in orthopedic surgery.
The infection rate is 2.2 % after primary total hip arthro-
plasty [1] and 2.0 % following spinal operations [2],
despite strict antiseptic operative procedures, which
include systemic prophylaxis. Infection rates of 13 % have
been described for endoprosthetic replacement of large
bone defects after tumor resection, while external fixation
leads to infection in up to 70 % of cases [3, 4]. Various
biomaterial surface treatments have been developed to
improve prophylaxis against implant-related infections.
There have been investigations of the covalent attachment
of polycationic groups [5], implantation of Ca?, N? and
F? ions [6], impregnation and loading of chitosan nano-
particles with antimicrobial agents [7]. Other treatments of
implant surfaces are drug-loaded polymers, quaternary
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ammonium compounds, human serum albumin and silver
ions [8–11]. The antimicrobial properties of silver have led
to its use as a coating for medical devices [12, 13]. While
various coatings have been devised using silver salts or ion
beam implantation of metallic silver, they have produced
either disappointing clinical results [14–16] or further
complications [17, 18]. The shortcomings of these pro-
posed techniques are limited chemical stability, local
inflammatory reactions due to material composition and a
lack of controlled release kinetics from the coatings.
In this study, we used titanium implants with surfaces
that were modified using anodization. Biocompatible
metal-oxide implants have current clinical applications in
orthopedic and dental implants [19]. As a biocompatible
material, titanium and its alloys, particularly Ti–6Al–4V,
are extensively used in orthopedic and dental implants. The
excellent biocompatibility of titanium is reportedly attrib-
utable to the stable oxide that readily forms on its metal
surfaces [20]. The composition of highly adhesive anodic
oxide films that form through anodization is dependent on
the electrolyte composition [21]. Povidone-iodine can also
be used as an electrolyte, resulting in the formation of an
adhesive, porous anodic oxide with the antiseptic proper-
ties of iodine [22]. Iodine is a component of thyroid hor-
mones and is the heaviest essential element needed by all
living organisms. Our previous studies indicate that iodine-
supported titanium has antibacterial activity, biocompati-
bility and no cytotoxicity [22].
Patients and methods
This study was approved by the institutional review board
at the University of Kanazawa. Between July 2008 and
June 2011, 222 patients with postoperative infection or
compromised status were recruited into a prospective
cohort study and treated with iodine-supported implants.
Informed consents were obtained from the patients and
their family. They were informed that new antibacterial
implants were used for prophylaxis and treatment of
postoperative infections.
The mean age of the patients was 49.4 years (range
5–85 years). One hundred twenty-seven patients were male
and 95 were female. Patients were tested for iodine aller-
gies with patch tests before surgery. The diagnoses inclu-
ded 95 cases of tumor (42.8 %), 34 cases of limb deformity
(15.3 %), 29 cases of degenerative disease (13.1 %), 27
cases of osteomyelitis (12.2 %), 24 cases of pseudoar-
throsis (10.8 %) and 16 cases of fracture (7.2 %). Iodine-
supported implants were used to prevent infection for 158
patients (prevention group) who were likely to be infected,
such as those with cancer, diabetes mellitus, and under
steroid administration or chemotherapy, as well as those
with compromised conditions such as open fracture (Gu-
stilo type 2, 3-a, 3-b, 3-c) and long-term external fixation;
and to treat active infections (Staphylococcus, Escherichia
coli, fungus, etc.) in 64 patients (treatment group). Thirty-
eight patients underwent one-stage revisions, while 26
needed two-stage revisions. Postoperatively, all patients
received antibiotics intravenously for 3–7 days, followed
by oral administration until wound healing was achieved.
The iodine supports were produced by the Chiba Insti-
tute of Technology (Narashino, Japan) using a technique
described by Hashimoto [23]. The thickness of the anodic
oxide film was between 5 and 10 lm, with more than
50,000 pores/mm2 with the capacity to support 10–12 lg/
cm2 iodine (Fig. 1a, b). Postoperative radiological evalu-
ations were performed regularly, during which time loos-
ening and failure of the implants was checked by two
specific radiological specialists (HT and TS). Moreover,
the chronological changes of the iodine amount were
evaluated using half pins removed after completion of
external fixation.
White blood cells (WBCs) and C-reactive protein (CRP)
were measured pre- and postoperatively in all patients. In
patients with implant infections, a cure with no clinical
signs of inflammation, a normal WBC level and a negative
CRP were assessed by the treating clinician at the date of
10 um
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Fig. 1 Electron micrograph of the oxide layer: more than 50,000
pores/mm2 (a). Diagram of the anodizing porous membrane (b)
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the last available follow-up. The levels of thyroid hor-
mones in the blood, thyroid-stimulating hormone (TSH),
free triiodothyronine (FT3) and free thyroxine (FT4) were
examined to determine if iodine from the implant influ-
enced physiological activities. Both examinations were
conducted regularly for 1 year.
Results
The mean follow-up period was 18.4 months (range
3–44 months). The following types of implants were used:
82 spinal instrumentations (Fig. 2), 55 plates for osteo-
synthesis (Fig. 3), 36 external fixations (pins and wires)
(Fig. 4), 32 tumor prostheses (Figs. 5, 6), 10 hip prosthe-
ses, 4 knee prostheses (Fig. 7), 2 nails and 1 cannulated
screw. Acute infection developed in three tumor cases
(1.9 %) among the 158 patients under preventive care. In
one patient who had synovial sarcoma of the spine, surgical
site infection occurred during bone-marrow suppression
due to chemotherapy. The infection was cured by
debridement and removing only the Marlex mesh while
leaving the iodine-coated implants in place. One case with
osteosarcoma of the proximal femur received a prosthetic
reconstruction, while another received a total en bloc
spondylectomy for a metastatic spinal tumor. The two
infected cases were also cured by intravenous administra-
tion of antibiotics only, without removal of the implants.
The 64 treatment cases that underwent one-stage or two-
stage revision surgery recovered without additional sur-
gery. Among patients with active infection, one showed
late hematogenous infection 2 years after revision surgery
and one had a suspected iodine allergy. In all cases, there
were no signs of infection at the time of the last follow-up.
In the treatment group, median WBC levels were in the
normal range (Fig. 8), and median CRP levels returned to
\0.5 within 4 weeks after surgery (Fig. 9). In the pre-
vention group, these levels showed the same tendency
(Figs. 8, 9). Abnormalities of thyroid gland function were
not detected (Fig. 10).
None of the implants loosened during the follow-up
period. However, two patients (0.9 %) experienced
mechanical implant failure and were treated by re-
implantation and bone grafts. Radiograms revealed excel-
lent bone ingrowth and ongrowth around hip and tumor
prostheses (Fig. 11). Redness or discoloration of the
wounded area was not observed at the latest follow-up.
The amount of iodine on the removal external fixation
pins decreased by about 50 % after half a year and 1 year
later decreased to 20–30 % (Fig. 12).
Fig. 2 Case of a 57-year-old
man with pyogenic spondylitis
due to cord injury. Spinal pus
sinus (a). Debridement was
performed with primary
instrumentation using iodine-
supported titanium (b). The
infection was cured and
the fistula was closed after
surgery (c)
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Discussion
The results of this clinical trial suggest that iodine-sup-
ported titanium implants can be very effective in the
prevention and treatment of infections after orthopedic
surgery. Implant surgeries are used in almost all fields of
modern medicine and are associated with a definitive risk
of bacterial infection. Staphylococci account for the
Fig. 3 Case of a 42-year-old
man. Gustilo grade IIIa open
fracture (a). Primary internal
fixation using iodine-supported
titanium plate (b). No sign of
infection and good callus
formation at 4 months after
surgery (c). Iodine did not
inhibit bony union
Fig. 4 Case of a 64-year-old
woman with a right clubfoot due
to polio. Right clubfoot and
ulceration with MRSA infection
(a). External fixation performed
to correct the right foot
deformity (b). The iodine-
supported pin tract site was still
clean during the follow-up
period (c)
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majority of infections of both temporarily and permanently
implanted orthopedic devices. Although surgical site
infection rates in orthopaedic surgery are generally about
2 % [1, 2], it is more than 10 % in compromised hosts, and
in patients with open fracture and external fixation [3, 4,
24, 28]. In this study, postoperative infection occurred in
Fig. 5 Case of a 19-year-old woman with osteosarcoma of the left
femur. Postoperative coagulase-negative staphylococcus infection (a).
Primary revision surgery using iodine-supported tumor prosthesis (b).
No sign of infection after surgery (c). CRP was 0.1 mg/dl and WBC
was 4,400/ll 10 months later
Fig. 6 Case of a 74-year-old
man with long-lasting MRSA
arthritis of the right knee joint
due to an open fracture in
childhood. Continuous
irrigation and suction (a).
Secondary revision surgery
using an iodine-supported tumor
prosthesis; no sign of infection
15 months after surgery (b)
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3 of 158 (1.9 %) prophylaxis cases. All three were cancer
patients. The 1.9 % infection rate was lower than the his-
torical infection rate. Because drug resistance can prevent
systemic administration of antibiotics from providing
effective treatment for implant infections, it is important
that the coating of the implant possesses local antibacterial
activity. In order to reduce the incidence of implant-asso-
ciated infections, several biomaterial surface treatments
have been proposed [5–13]. There have also been reports
on antibacterial alloy implants [25, 26]. In particular, silver
has raised the interest of many investigators because of its
good antimicrobial action and low toxicity [11–13],
although some toxicity against human cells has been
observed [14, 18]. It was reported at the ‘‘29th Annual
Meeting of the European Bone and Joint Infection Society’’
in 2010 that 33 % (4/12) of patients classified as high-risk
types, with chronic infections and major bone loss, devel-
oped localized cutaneous argyria after receiving silver-
coated megaprostheses. In our opinion, silver-coated
implants can present many problems clinically, such as
cytotoxicity and no osteoconduction. Implants have also
been coated with antiseptics such as chlorhexidine [27].
Iodine is also an antiseptic agent. However, there are no
reports of the use of iodine-treated implants. This study is
Fig. 7 Case of a 72-year-old
woman with refractory fungal
arthritis after left total knee
arthroplasty. Secondary revision
surgery using iodine-supported
prosthesis. The knee fungal
arthritis healed following
surgery (24 months)
Fig. 8 The levels of WBC/ll in the prevention group and the treatment group: In both groups, although WBC levels tended to be high 2 weeks
after the operation, median WBC levels were in the normal range
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the first clinical trial of an iodine-coated implant. By an
oxidizing action, iodine denatures protein and kills a
microorganism. The antibacterial spectrum of iodine is
very broad, acting not only on general bacteria but also
viruses, tubercle bacilli and fungi (Fig. 13). From a basic
experiment, it is enough to inhibit the growth of Staphy-
lococcus and Escherichia coli completely if the surface of
the titanium implants has an iodine concentration of
2–3 lg/cm2 (data not shown). In addition, iodine does not
cause phenomena such as drug resistance induced by the
administration of antibiotics. Moreover, iodine is a trace
metal and an essential component of the thyroid hormone.
If iodine is released from the implant, it is biologically safe
because it can be excreted by the kidneys. In this study,
Fig. 9 The CRP levels (mg/dl) in the prevention group and the treatment group: In both groups, median CRP levels returned to \0.5 within
4 weeks after surgery
Fig. 10 The TSH levels (lIU/ml), FT3 levels (pg/ml) and FT4 levels (ng/dl), which are thyroid hormone levels: TSH, FT3 and FT4 levels were
in the normal range during the study period
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TSH, FT3 and FT4 levels were in the normal range during
the study period. Therefore, abnormalities of thyroid gland
function were not detected.
It is a key point in this study that all three infected
patients in prevention cases recovered without removing
the implants even if infection occurred. It is usually diffi-
cult to cure infections without removing the implants if an
implant-associated infection arises. However, we propose
that recovery was possible in the presence of the iodine-
coated implants because iodine-supported implants have
antimicrobial effects. Therefore, these antibacterial iodine-
coated implants are an innovative breakthrough.
Based on the medical literature, the successful eradica-
tion of a total joint replacement infection with a two-stage
re-implantation protocol is over 90 %, while the success
rate with a one-stage protocol is approximately 80 % [29].
In this study, we used iodine-supported implants in 56
patients for treating infection. However, reactivation of
infection was not seen in either one-stage or two-stage
revisions. The treatment strategy for postoperative infec-
tion was to perform two-stage revision surgery for active
infections of extremities (patients with active discharge
from sinuses or abscess formation), and one-stage revision
surgery for inactive or already subsided infections. One-
stage revision was performed as an exception for con-
ducting chemotherapy to lung metastasis, although the
osteosarcoma case (Fig. 5) had active infection. All
Fig. 11 Excellent bone ingrowth (filled triangle) and obvious spot
welds (upward arrow) were found around the hip prosthesis
I 2(
%)
Fig. 12 Iodine amount of half pin surface removed after treatment. Iodine was measured by X-ray fluorescent analysis (n = 25)
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patients with spinal infection were treated by one-stage
revision surgery. The principles of revision are the removal
of all possible infected tissue and bone with radical
debridement. Antibiotics are systemically administered in
conjunction with an antibiotic-loaded cement.
Median WBC levels remained below normal range
(\8,000/ll) throughout the study, and CRP levels showed
an increase within 4 weeks after surgery in both the
treatment group and prevention group. The normalization
of CRP was delayed by a postoperative reaction and the
effects of an underlying disease such as cancer, diabetes
and rheumatoid arthritis.
Bone conduction is reportedly not possible on certain
materials such as silver and copper [30]. In this study,
excellent bone ingrowth and ongrowth were shown around
hip and tumor prostheses on radiograms. There were no
signs of bone absorption or inhibition of bone formation.
Previous studies have demonstrated that iodine-supported
implants have excellent osteoconduction and good bio-
compatibility [22]. We think that the osteoconductive
effects were reinforced according to the porous structure of
the oxide layer.
Implant-associated infections were either prevented or
cured in all patients by the iodine coating. Further studies
with a longer follow-up period and with all replacement
sites will follow. We plan to compare the prospectively
collected data for the iodine-supported titanium group with
retrospectively collected data for a titanium group to
ascertain how long the iodine advantage is maintained in
the body. At present, it is clear that 20–30 % of iodine
remained on external fixation pins that were removed after
1 year (Fig. 12). We plan to measure the change in the
amount of iodine for every kind of implant or insertion.
The amount of iodine will be determined by the thickness
of the oxide layer.
Regarding the limitation of this study, the infection rate
of the prevention group was compared to a historical
control. Therefore, a multi-center prospective randomized
clinical trial on a large scale is necessary to demonstrate
the statistical significance of the infection rate in the future.
Conclusions
A clinical trial of iodine-supported titanium implants was
performed with no detection of cytotoxic or adverse
effects. The titanium was implanted at infectious lesions
with no problems, as infections subsided because of the
antibacterial activity of the implant. Moreover, iodine-
supported implants worked to prevent postoperative
infections in patients with compromised status. Therefore,
the povidone-iodine coating is promising and can be
applied to all titanium implants for preventing and treating
infections following orthopedic surgery.
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